A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). (Q35583855)
Jump to navigation
Jump to search
scientific article published on 10 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). |
scientific article published on 10 December 2010 |
Statements
1 reference
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). (English)
1 reference
Tanios Bekaii-Saab
1 reference
Cancer and Leukemia Group B
1 reference
Eileen M O'Reilly
1 reference
Donna Niedzwiecki
1 reference
Margaret Hall
1 reference
Donna Hollis
1 reference
Timothy Pluard
1 reference
Kathe Douglas
1 reference
Ghassan K Abou-Alfa
1 reference
Hedy L Kindler
1 reference
Richard L Schilsky
1 reference
Richard M Goldberg
1 reference
10 December 2010
1 reference
1 reference
1 reference
Identifiers
1 reference